Search

Take a look back at some of the year’s biggest news in cancer research.

… Thursday, December 27, 2018 December wouldn’t be complete without a recap of the year’s most important scientific advances in cancer. Memorial Sloan Kettering scientists published hundreds of studies this past year and weighed in as experts on many others. Below are some of the year’s highlights.   1

New research from MSK develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia; identifies a transcription factor that orchestrates natural killer cell response; and finds vepafestinib is a promising therapeutic for the treatment of RET-driven cancers.

… Friday, September 29, 2023 New research from Memorial Sloan Kettering Cancer Center (MSK) develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia; identifies a transcription factor that orchestrates natural killer cell response; and finds vepafestinib is a promising

Read about a few of the MSK studies being presented at the 2019 American Society of Clinical Oncology's annual meeting.

… Monday, June 3, 2019 Summary Memorial Sloan Kettering researchers were involved in hundreds of studies being presented at the American Society of Clinical Oncology’s 2019 annual meeting. These are a few of the highlights. Each year in Chicago, tens of thousands of doctors, nurses, and researchers meet

New researched published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options for patients with advanced hepatocellular carcinoma the most common form of liver cancer.

… Wednesday, July 4, 2018 Bottom Line: New researched published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options for patients with advanced hepatocellular carcinoma the most common form of liver cancer . The data, originally

A new study from researchers at Memorial Sloan Kettering Cancer Center has found that the majority of surgeons treating prostate cancer in the United States have extremely low annual caseloads, potentially leading to increased rates of both surgical complications and cancer recurrence.

… Wednesday, November 18, 2009 A new study from researchers at Memorial Sloan Kettering Cancer Center has found that the majority of surgeons treating prostate cancer in the United States have extremely low annual caseloads, potentially leading to increased rates of both surgical complications and cancer

Learn how a bladder cancer specialist diagnosed with a very rare form of the disease turned to MSK for its expertise.

… Friday, May 26, 2017 Summary Burt Needles had been practicing urologic oncology for 30 years when he was diagnosed with a rare, aggressive form of bladder cancer . Realizing he needed treatment by doctors who had experience with this disease, he turned to MSK. Burt Needles was not worried when the first

Learn why it's important to get a flu shot this year.

… Friday, September 13, 2024 Anyone can get the flu, which is why everyone should get a flu shot. The flu can be an especially serious illness for people with cancer and their caregivers. Memorial Sloan Kettering infectious disease specialist Monika Shah answers common questions that people with cancer

Memorial Sloan Kettering Cancer Center (MSK) experts shared the results of their cutting-edge research at the European Society of Medical Oncology (ESMO) Congress 2023, held in Madrid, Spain, October 20 to 24, 2023. Highlights included promising advances for difficult-to-treat gastric, breast, and head and neck cancer, and a recent molecular genetics discovery.

… Wednesday, October 25, 2023 Update: Lead author Dr. Bob Li and international colleagues published this study in Lancet Oncology in May 2024. It is the first tumor-agnostic study of a HER2-directed antibody-drug conjugate in patients with solid tumors harboring activating HER2 mutations. The results showed

Dose-dense chemotherapy calls for less time between doses compared with a standard treatment plan.

… Wednesday, December 6, 2017 VIDEO | 01:09 Larry Norton Explains the Development of Dose-Dense Chemotherapy and His Hopes for the Future Hear medical oncologist Larry Norton describe how dose-dense chemotherapy was developed for breast cancer and his hopes for the future of research. Video Details Summary

How cryo-electron microscopy is providing scientists at MSK with an unprecedented view of the wild and wiggly microcosm inside our cells.

… Friday, September 20, 2024 Boxy, sleek, and fronted with dark glass, it looks more like a 10-foot-tall wine fridge than a multimillion-dollar microscope. But this technological marvel is providing scientists at Memorial Sloan Kettering Cancer Center (MSK) with an unprecedented view of the wild and wiggly